Here’s Why The Medicines Company Jumped Higher Again Today
A buyout rumor has investors hopeful.
The Medicines Company
MDCO
MDCO
$70.21
$11.56
19.7%
BATS BZX Real Time Price as of November 19, 2019, 4:00 p.m. EST
View Interactive MDCO Charts
A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace.
News & Analysis: The Medicines Company
The Fool has written over 100 articles on The Medicines Company.
Here's Why The Medicines Company Moved Higher Today
Clinical data for cholesterol-lowering drug inclisiran looks good.
Medicines Co (MDCO) Q3 2019 Earnings Call Transcript
MDCO earnings call for the period ending September 30, 2019.
The Medicines Company Surges on Positive Drug Trial Results
The company's flagship cholesterol treatment shows major potential.
The Medicines Company Is Up 161% Year to Date, but Here's a Better Way to Play the Drugmaker's Success
Investors should go to the source.
Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy
Amgen is acquiring Otezla, and The Medicines Company unveils stellar data for its cholesterol treatment.
What Happened in the Stock Market Today
On a day when trade worries and weak economic data hurt stocks, Medicines Company rose on a successful drug trial and Boston Beer fell following a downgrade.
Here's Why The Medicines Company Stock Soared Again on Tuesday
A detailed look at a big clinical trial did not disappoint.
Why Tilray, Conn's, and Medicines Company Jumped Today
These stocks managed to overcome a big market downdraft.
Here’s Why The Medicines Company Shares Jumped 13.8% Today
The biotech got good news on a clinical trial.
